Delivery Order SPE2DE24D0013-SPE2D626F3182
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,654.60 firm fixed-price delivery order (Contract No. GXCT/NG-10) by the Defense Logistics Agency's Medical Supply Chain division on May 6, 2025, with an ultimate completion date of May 13, 2025. The contract carries no set-aside designation and will be performed in Sunnyvale, California. This delivery order represents a continuation of Cepheid's ongoing relationship with the federal...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,760 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which carries no set-aside designation, has an ultimate completion date of July 25, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with Cepheid's existing Indefinite...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,880.04 by the Defense Logistics Agency Medical Supply Chain on October 17, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by October 24, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F3182Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects the Defense Logistics Agency's continued reliance on Cepheid as a critical supplier of infectious disease diagnostic testing solutions to support federal healthcare operations. Cepheid maintains an extensive federal contracting presence across multiple healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, with a demonstrated specialization in rapid molecular diagnostic testing for conditions including COVID-19, influenza, respiratory syncytial virus, and drug-resistant tuberculosis. The company holds significant indefinite delivery contracts with the VA, including a $32.8 million vehicle with VISN 6 extending through September 2030, which establishes the framework for ongoing procurement of diagnostic reagents and assays across the federal healthcare system. This delivery order award continues Cepheid's role as a foundational supplier of molecular diagnostic capabilities to support clinical laboratory operations and infectious disease testing requirements across federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 10/20/25 |